MANE Veradermics, Incorporated
$140.72▲ +2.42%
Healthcare
Other
After hours
$140.72▲ +0.00%
Oct 27, 4:00 PM ET
Volume 466.6K
Avg Volume (10D) 754.1K
Key Metrics & Fundamentals
Market Cap
$5.88B
P/E Ratio
–
Div Yield
0.00%
52W Range
32.00 - 141.75
% vs 50 MA
24.98%
% vs 200 MA
–%
RSI-14
66.1
MACD Histogram
+1.9700
Beta (1Y vs SPY)
1.06
Free Cash Flow
-$14.51M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$29.55M
COGS
–
Operating Exp
$29.55M
Operating Income
-$29.55M
EBIT
-$29.55M
Pretax Income
-$23.50M
Net Income
-$23.50M
EPS (Diluted)
-0.58
Price & Volume History
Loading chart…
Recent News
Why This Hair Restoration Biotech's Shares Are Soaring
Motley Fool · Oct 25, 2026 9:20 AM ET
B. Riley Raises Price Target on Veradermics to $204 From $170, Keeps Buy Rating
MT Newswires · Oct 22, 2026 8:07 AM ET
Could This Pill Be a Game Changer for Hair Loss? Veradermics Reports Major Breakthrough
Benzinga · Oct 22, 2026 6:24 AM ET
Veradermics’ stock up on male hair loss trial success
Clinical Trials Arena · Oct 19, 2026 1:18 PM ET
Veradermics Soars 10% as Phase 3 Data Show Oral Hair-Loss Pill Could “Transform” Treatment
TIKR · Oct 19, 2026 1:07 PM ET
Veradermics Phase III Hair Loss Trial Meets All Endpoints, Posts Strong Growth Results
MarketBeat · Oct 19, 2026 1:02 PM ET
Veradermics stock surges as hair loss drug meets Phase 3 goals
Investing.com · Oct 19, 2026 9:50 AM ET
Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study
BioPharma Dive · Oct 19, 2026 9:14 AM ET
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 ‘304’ Clinical Trial in Male Pattern Hair Loss
Business Wire · Oct 19, 2026 7:00 AM ET
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
Business Wire · Oct 18, 2026 6:00 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MANE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.